Company / Capital Expenditures
MANNKIND CORP Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$4.6M
FY2025
5-year range
$4.6M / $42.4M
FY2021-FY2025
Trend
-52.9%
vs FY2024
Sector context
#74 of 192
Health Care
What the data says
At $5M, MANNKIND CORP's capital expenditures ranks #74 of 192 in the Health Care sector. Capital Expenditures has fluctuated over the past 9 years, ranging from $354,000 in FY2018 to $42M in FY2023.
Based on SEC 10-K filings.
$5M in FY2025 with a 5-year CAGR of +41.6%.
Declined from $42M to $5M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -15.6%
- 5-Year CAGR
- +41.6%
- 10-Year CAGR
- -
Sector benchmark
#74 of 192 in Health CareTop 39% of 192This company $4.6M Sector average $118.6M
▼
-96.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +41.6%, indicating consistent growth.
- In FY2025, capital expenditures decreased 52.9% year-over-year.
- Ranks #74 out of 192 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.74 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.6M | -52.9% |
| FY2024 | $9.7M | -77.2% |
| FY2023 | $42.4M | +459.2% |
| FY2022 | $7.6M | -33.8% |
| FY2021 | $11.5M | +1331.5% |
| FY2020 | $801.0K | -68.8% |
| FY2019 | $2.6M | +624.6% |
| FY2018 | $354.0K | - |
| FY2017 | - | - |
| FY2016 | $1.1M | -88.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026